Gilead Sciences increases dividend by 9.3 percent in 2016 Dividendhike.com | Dividend News and Statistics for US Equities

Headlines

PSX - Phillips 66 hikes dividend by 9.5% AOS - A.O. Smith hikes dividend by 6.7% to $0.32 quarterly per share LMT - Lockheed Martin hikes dividend by 5% to $3.15 quarterly per share MCD - McDonald's hikes dividend by 9.9% to $1.67 quarterly per share AFG - American Financial Group hikes dividend by 12.7% to $0.71 quarterly HON - Honeywell hikes dividend by 4.9% to $1.08 quarterly per share HWM - Howmet Aerospace hikes dividend by 25% to $0.05 quarterly per share CNP - Centerpoint Energy hikes dividend by 5.3% to $0.20 quarterly per share FE - FirstEnergy Corp hikes dividend by 5.1% to $0.41 quarterly per share TXN - Texas Instruments hikes dividend by 4.8% to $1.30 quarterly per share SBUX - Starbucks hikes dividend by 7.5% to $0.57 quarterly per share MSFT - Microsoft hikes dividend by 10.3% to $0.75 quarterly per share KDP - Keurig Dr Pepper hikes dividend by 7.5% to $0.215 quarterly per share O - Realty Income hikes monthly dividend by 0.2% to $0.256 per share EG - Everest Group hikes dividend by 6.1% to $1.75 quarterly per share

Business	yield	Hike yrs	5 yr CAGR	freq.	paid since
Gilead Sciences As of October 10, 2023	ticker	dps (an.)	2024 hike	2023 hike	2022 hike
Gilead Sciences As of October 10, 2023	GILD	$3.00	2.7%	2.8%	4.4%
Biotechnology	3.9%	8	5.6%	Quarter	2015

Gilead Sciences hikes dividend by 9.3%

Tuesday 2 February 2016

Gilead Sciences (GILD) will raise its quarterly dividend by 9.2 percent to $0.47 per share in 2016. This marks the first ever dividend hike for the biopharmaceutical company. Gilead initiated a $0.43 per share quarterly dividend last year.

The next dividend is payable on June 29, 2016, to shareholders of record as of June 16, 2016. The ex-dividend date is June 14, 2016. Gilead pays quarterly dividends at the end of the month in March, June, September and December.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company's principal areas of focus include human immunodeficiency virus (HIV), liver diseases (hepatitis C and hepatitis B), cardiovascular, hematology/oncology and inflammation/respiratory. Gilead became a public company in 1992 and has been paying a dividend since 2015.

Gilead Sciences

Health Care

Dividend Calendar